Discontinued — last reported Q3 '20
HCA Healthcare Excess Tax Benefits from Share-Based Compensation remained flat by 0.0% to -$13.75M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 39.6%, from -$22.75M to -$13.75M. Over 2 years (FY 2023 to FY 2025), Excess Tax Benefits from Share-Based Compensation shows an upward trend with a -19.1% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase generally signals strong stock performance and positive tax cash flow, though it can be volatile based on market conditions.
Represents the tax benefit realized when the actual tax deduction from employee stock-based compensation exceeds the cum...
Standard metric for companies with significant equity-based compensation programs.
is_tmo_excess_tax_benefits_share_based_compensation| FY'23 | FY'24 | FY'25 | |
|---|---|---|---|
| Value | -$84.00M | -$91.00M | -$55.00M |
| YoY Change | — | -8.3% | +39.6% |